Skip to main content
. 2015 May 29;6(21):18631–18640. doi: 10.18632/oncotarget.4072

Figure 3. Association of serum miR-26a expression with progression-free and overall survival.

Figure 3

A. and B. Kaplan-Meier graphs representing the probabilities of progression-free and overall survival in CCA patients according to expression level of miR-26a. Two-tailed Student's t test was used to analyze the significant differences. *P < 0.05.